Modified mRNA as a Therapeutic Tool for the Heart

Area of Science:

• Biotechnology
• Cardiovascular Medicine
• Genetic Medicine

Background:

• Heart disease is a major global health burden, necessitating novel therapeutic strategies.
• Messenger RNA (mRNA) technology has evolved, with modified mRNA (modRNA) showing significant potential for therapeutic applications.
• modRNA offers advantages over traditional gene therapy vectors, including transient protein expression and reduced immunogenicity.

Purpose of the Study:

• To review the advantages of modRNA-based gene delivery for cardiac repair compared to traditional vectors.
• To provide a comprehensive overview of modRNA's role in promoting cardiomyocyte proliferation, cardiac vascularization, and preventing apoptosis.
• To highlight recent advancements in modRNA delivery strategies and discuss challenges for clinical translation.

Main Methods:

• Literature review comparing modRNA with traditional gene therapy vectors for cardiac applications.
• Analysis of modRNA's mechanisms in promoting cardiac regeneration and protection.
• Examination of current modRNA delivery systems and their clinical feasibility.

Main Results:

• modRNA enables transient yet potent protein translation, crucial for therapeutic gene expression.
• modRNA exhibits low immunogenicity and minimal risk of insertional mutagenesis, enhancing safety.
• modRNA demonstrates potential in stimulating cardiomyocyte proliferation, enhancing vascularization, and preventing cardiac cell death.

Conclusions:

• modRNA represents a promising therapeutic platform for cardiac repair and treating heart disease.
• Further development of modRNA delivery strategies is essential for successful clinical translation.
• modRNA technology offers a safe and effective alternative to traditional gene therapy for cardiovascular conditions.